Wuxi Grandchamp Pharmaceutical Technology Co., Ltd Patent applications |
Patent application number | Title | Published |
20120196802 | MODIFIED EXENDINS AND USES THEREOF - The present invention discloses a modified exendin or pharmaceutically acceptable salts thereof, wherein the modified exendin comprises an amino acid sequence having at least 90% sequence identity to SEQ ID No. 17 and the amino acid sequence has a higher stability than the non-modified exendin of SEQ ID No. 4. These compounds are useful in treating type 2 diabetes as GLP-1 receptor agonists. | 08-02-2012 |
20100009904 | Modified Exedins and Uses Thereof - Novel exendins with modifications at one or more of following positions: 2, 14, 27 or 28 and polyethylene glycol derivatives thereof are provided. These compounds are useful in treating type 2 diabetes as GLP-1 receptor agonists. | 01-14-2010 |